Monoclonal antibody therapy in hematological malignancies
Terui, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 217-221
2012
ISSN/ISBN: 0047-1852 PMID: 23133956 Document Number: 662326
Document emailed within 1 workday
Related Documents
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861Ozawa, K. 2010: Gene therapy for hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 619-622
Ezaki, K. 1996: Cytokine therapy for hematological malignancies International Journal of Hematology 65(1): 17-29
Resegotti, L. 1993: The therapy of hematological malignancies in the elderly Haematologica 78(3): 141-144
Aderka, D.; Levo, Y. 1986: Interferon therapy in hematological malignancies Harefuah 110(8): 400-405
Hutas, G. 2008: Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies Current Opinion in Investigational Drugs 9(11): 1206-1215
Moroz, C.; Bessler, H.; Lurie, Y.; Shaklai, M. 1987: New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies Experimental Hematology 15(3): 258-262
Nagura, E.; Kawashima, K. 1986: Secondary malignancies associated with hematological malignancies following anticancer treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 2): 1464-1474
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Douillard, J.Y.; Laborda, J.; Burg, C.; Ridge, J.; Levenbook, I.; Blottière, H.; Sela, B.; Hoffman, T.; Ben Ami, S. 1989: Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors Cancer Research 49(3): 687-692
Kawata, A.; Yoshida, M.; Okazaki, M.; Yokota, S.; Barcos, M.; Seon, B.K. 1994: Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody Cancer Research 54(10): 2688-2694
Okamura, S.; Ikematsu, W. 1993: Hematological malignancies with eosinophilia Nihon Rinsho. Japanese Journal of Clinical Medicine 51(3): 800-805
Itälä, M. 1998: First monoclonal antibody accepted for cancer therapy Duodecim; Laaketieteellinen Aikakauskirja 114(6): 509; 511
Ishii, T.; Saeki, Y. 2002: Monoclonal antibody therapy for rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 60(3): 551-555
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Takeshita, A.; Ohno, R. 2000: New combination therapies in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 388-394
Kennel, S.J.; Lankford, T.; Flynn, K.M. 1983: Therapy of a murine sarcoma using syngeneic monoclonal antibody Cancer Research 43(6): 2843-2848
Jha, A. 2013: Spectrum of hematological malignancies and peripheral cytopenias Journal of Nepal Health Research Council 11(25): 273-278
Jonker, M.; Schellekens, P.T.; Harpprecht, J.; Slingerland, W. 1991: Complications of monoclonal antibody (MAb) therapy: the importance of primate studies Transplantation Proceedings 23(1 Part 1): 264-265
Inazawa, J.; Abe, T. 1992: Applications of FISH to chromosome analysis in hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1298-1303